Referenslitteratur
för:
eye q |
|
| |
FÖRFATTARE
OCH TIDSKRIFT |
PUBLICERAD |
HÄMTA
PDF |
| |
|
|
|
| |
1. Haag M. Essential fatty acids and the brain.
Can J Psychiatry 48: 195-203; 2002.
|
2002 |
|
| |
2.
Peet M, Brind J, Ramchand CN et al.
Two double-blind placebo-controlled pilot studies of eicosapentaenoic
acid in the treatment of schizophenia.
Schizophrenia Research 49(3):243-51
|
|
|
| |
3. Peet
M, Horrobin DF.
A dose-ranging study of the effects of ethyl-eicosapentaenoate in
patients with ongoing depression despite apparently adequate treatment
with standard drugs.
Arch Gen Psychiatry 59(10):913-9; 2002
|
2002 |
|
| |
4. Richardson
AJ, Puri BK.
A randomized double-blind, placebo-controlled study of the effects
of supplementation with highly unsaturated fatty acids on ADHD-related
symptoms in children with specific learning difficulties.
Prog Neuropsychopharm Biol Psychiat 26(2):233-9; 2002
|
2002 |
Hämta
här |
| |
5. Richardson AJ, Montgomery P.
The Oxford-Durham Study: A Randomized, Controlled Trial of Dietary Supplementation with Fatty Acids in Children with Developmental Coordination Disorder.
Pediatrics 115: 1360-1366; 2005
|
2005 |
Hämta här |
| |
6. Birch
EE, Hoffman DR, Castaneda YS, et al.
A randomized controlled trial of long-chain polyunsturated fatty acid
supplementation of formula in term infants after weaning at 6 weeks
of age.
Am J Clin Nutrition 75:570-80; 2002
|
2002 |
|
| |
7. Peet M.
Essential fatty acids: theoretical aspects and treatment implications
for schizophrenia and depression.
Advances in Psychiatric Treatment
8:223-9; 2002
|
2002 |
Hämta
här |
| |
8. Bell G.
Phospholipid Spectrum Disorders in Autism.
|
2002 |
Hämta
här |
|
|